spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:   eShunt 

 HSMN NewsFeed - 29 Oct 2026
CereVasc Receives FDA IDE Approval to Evaluate the eShunt(R) System in Patients with Alzheimer's Disease
Devices Neurology Interventional FDA
 HSMN NewsFeed - 15 Sep 2026
CereVasc, Inc. Appoints Tony Kingsley as President and Chief Executive Officer
Devices Interventional Neurosurgery Personnel
 HSMN NewsFeed - 30 Jul 2026
CereVasc Opens New Massachusetts Facility in Preparation for eShunt(R) System Commercialization
Devices Neurosurgery
 HSMN NewsFeed - 23 Jun 2026
CereVasc, Inc. Completes Enrollment in STRIDE Pivotal Trial of the eShunt(R) System
Devices Neurosurgery
 HSMN NewsFeed - 4 Jun 2026
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt(R) System for the Treatment of Normal Pressure Hydrocephalus
Devices Interventional Neurosurgery Venture Capital
 HSMN NewsFeed - 4 Mar 2026
First-in-Human Use of CereVasc(R) eShunt(R) System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes
Devices Neurosurgery
 HSMN NewsFeed - 16 Jul 2024
CereVasc Announces Appointments of New Directors
Devices Neurosurgery Personnel
 HSMN NewsFeed - 13 May 2024
CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt(R) System for the Treatment of Normal Pressure Hydrocephalus
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 12 Jun 2023
FDA Clears CorNeat EverPatch, World's First Non-degradable, Synthetic Tissue Substitute for Ophthalmic Surgery
Devices Ophthalmology FDA
 HSMN NewsFeed - 28 Mar 2023
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
Devices Neurosurgery Personnel
 HSMN NewsFeed - 9 Aug 2022
CereVasc Announces FDA Approval of Second IDE Study of the eShunt(R) System
Devices Neurosurgery Interventional FDA
 HSMN NewsFeed - 8 Feb 2022
CereVasc Receives FDA IDE Approval to Begin Initial Clinical Study of the eShunt(R) System for Patients with Normal Pressure Hydrocephalus
Devices Interventional Neurosurgery FDA
 HSMN NewsFeed - 16 Jan 2019
Lisa Genova, Ph.D joins CereVasc Board of Directors
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 15 Sep 2017
New eShunt System Presented at the American Academy of Neurological Surgery Annual meeting in Santa Barbara, CA
Devices Neurosurgery
Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!